425 Participants Needed

Parental Medication Education for Preventing Medication Errors After NICU Discharge

HS
JV
JV
Overseen ByJessica Velazquez-Perez
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: NYU Langone Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This is a randomized controlled study of parents of children to be discharged from the neonatal intensive care unit at Bellevue and Elmhurst hospitals. A total of 425 subjects will be recruited across two sites over preparatory phases and two primary study phases.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

Is the Parental Medication Education program safe for humans?

The research articles focus on reducing medication errors in NICUs through educational strategies, but they do not provide specific safety data for the Parental Medication Education program or its variants like HELPix or HELPix+Tech.12345

How does the treatment HELPix, HELPix+Tech differ from other treatments for preventing medication errors after NICU discharge?

HELPix, HELPix+Tech is unique because it combines parental education with technology to prevent medication errors after NICU discharge. This approach focuses on improving parents' understanding and skills in medication management, which is not typically addressed by standard treatments.35678

What data supports the effectiveness of the treatment HELPix, HELPix+Tech for preventing medication errors after NICU discharge?

Research shows that educational interventions in NICUs can reduce medication errors, suggesting that HELPix, which likely includes educational components, might help parents prevent errors after discharge.12345

Who Is on the Research Team?

HS

Hsiang Sharon Yin

Principal Investigator

NYU Langone

Are You a Good Fit for This Trial?

This trial is for parents over 18, who speak English or Spanish, and are the primary caregivers administering at least one daily liquid medication to their child after discharge from the neonatal intensive care unit. Participants must have internet access, a mobile phone that can receive texts, and be able to return for follow-up visits.

Inclusion Criteria

Primary person who will administers child's medications
My child was sent home with a prescription for daily liquid medication.
I am the main person giving my child their medications.
See 1 more

Exclusion Criteria

Visual acuity worse than 20/50 according to the Rosenbaum Pocket Screener
Uncorrectable hearing impairment
Does not have access to internet (via computer/smartphone)
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Preparatory Phase

Preparatory activities for the study, including recruitment and initial setup

4 weeks

Intervention Phase

Parents receive usual care, HELPix, and/or HELPix+Tech interventions to support safe medication use

4 weeks
3 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after intervention

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • HELPix
  • HELPix+Tech
Trial Overview The study compares two methods of helping parents safely give medications: HELPix+Tech (a technology-based aid) versus HELPix alone. It's designed to see which method reduces medication errors after infants leave the hospital.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: HELPix+TechExperimental Treatment1 Intervention
Group II: HELPixExperimental Treatment1 Intervention
Group III: Usual CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

NYU Langone Health

Lead Sponsor

Trials
1,431
Recruited
838,000+

Published Research Related to This Trial

Implementing a feedback system for prescribers in the neonatal intensive care unit (NICU) led to an 83% improvement in the frequency of narcotic prescribing errors, increasing the number of days between such errors from 3.94 to 22.63 days.
However, the intervention did not significantly impact the frequency of antibiotic prescribing errors, indicating that while feedback can be effective for certain medications, additional strategies may be needed for others.
Personalised performance feedback reduces narcotic prescription errors in a NICU.Sullivan, KM., Suh, S., Monk, H., et al.[2022]
A comprehensive educational strategy significantly reduced the medication error rate in a regional neonatal intensive care unit from 20.7% to 3% after implementation, based on a review of 4182 drug orders.
The intervention also improved the correct identification of prescribing physicians from 1.3% to 78.2%, indicating enhanced accountability and safety in the prescription process.
Educational strategy to reduce medication errors in a neonatal intensive care unit.Campino, A., Lopez-Herrera, MC., Lopez-de-Heredia, I., et al.[2022]
A survey of 164 neonatal intensive care units (NICUs) revealed that while over 85% of them use electronic health records and computerized physician order entry, many still do not implement critical safety practices like barcoding and formal safety training.
The study highlights a significant variation in medication safety practices across NICUs, indicating a need for improvement to prevent adverse drug events (ADEs) and enhance infant health outcomes.
National Survey of Neonatal Intensive Care Unit Medication Safety Practices.Greenberg, RG., Smith, PB., Bose, C., et al.[2022]

Citations

Personalised performance feedback reduces narcotic prescription errors in a NICU. [2022]
Educational strategy to reduce medication errors in a neonatal intensive care unit. [2022]
National Survey of Neonatal Intensive Care Unit Medication Safety Practices. [2022]
The effect of a multifaceted educational intervention on medication preparation and administration errors in neonatal intensive care. [2022]
NICU medication errors: identifying a risk profile for medication errors in the neonatal intensive care unit. [2022]
Parents can dose liquid medication accurately. [2022]
Impact of Parent-Targeted eHealth on Parent and Infant Health Outcomes: A Scoping Review. [2019]
[Role of the nurse and midwife in educating parents of neonates treated at intensive care units]. [2011]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security